New Entity Recognition Mission Available
Pilocarpine is a drug that was frequently identified by our Mark2Cure citizen scientists and volunteers in the previous sets of biomedical literature. It was often found...
Happy St. Patty’s day!
Current progress in Mark2Cure Thanks to our wonderful community of citizen scientists and volunteers, the NFE2L1 entity recognition mission is now 99% complete! If you haven’...
Rare Disease Day 2017 is here!
As many of you already know, Mark2Cure is currently focused on the literature space surrounding NGLY1-deficiency due to the concerted effort this rare disease community made...
Upcoming Mark2Cure-related events
In September of 2015, the Citizen Science Association, announced the organization of a National Citizen Science Day which was scheduled for April 16, 2016. Unfortunately, the...
Mark2Cure Beta Study officially published
Mark2Cure’s first academic paper is finally published. For those of you who have been with us for a while, you may recall the posting of...